Tag: biotechnology products

March 27, 2018

5 Top NASDAQ Biotech Stocks of Q1 2018

The biotech industry is a unique intersection of companies. Here's a look at the top-gaining biotech companies on the NASDAQ...
March 16, 2018

Fortress Biotech Reports Fourth Quarter and Full-Year 2017 Financial Results

Fortress Biotech (NASDAQ:FBIO) a biopharmaceutical company dedicated to acquiring, developing and commercializing novel pharmaceutical and biotechnology products, today announced financial...
February 26, 2018

Fortress Biotech Announces Aevitas Therapeutics Enters Sponsored Research Agreement with the University of Massachusetts Medical School

Fortress Biotech (NASDAQ:FBIO), a biopharmaceutical company dedicated to acquiring, developing and commercializing novel pharmaceutical and biotechnology products, today announced that...
October 26, 2017

The State of Novel Alzheimer's Treatments

Alzheimer's already affects nearly five million Americans, with a growing population incoming, the need for an improved treatment is a...
January 3, 2017

Avenue Therapeutics Receives Notices of Allowance for Patent Applications

Avenue Therapeutics, Inc. (“Avenue”), a Fortress Biotech (NASDAQ:FBIO) Company, today announced that Notices of Allowance have now been received from...
December 28, 2016

Fortress Biotech Announces Publication on MB‐101 in New England Journal of Medicine

Fortress Biotech, Inc. (NASDAQ:FBIO) (“Fortress”), a biopharmaceutical company dedicated to acquiring, developing and commercializing novel pharmaceutical and biotechnology products, today...
October 5, 2016

Chugai's ACTEMRA/RoACTEMRA Receives Breakthrough Therapy Designation from FDA

Chugai Pharmaceutical announced that the US Food and Drug Administration has granted Breakthrough Therapy Designation to ACTEMRA®/RoACTEMRA® (tocilizumab), a Chugai...